Effects of age on human skeletal muscle: a systematic review and meta-analysis of myosin heavy chain isoform protein expression, fiber size, and distribution
American Journal of Physiology-Cell Physiology · 01.12.2024 · 327 (6) · C1400-C1415
DOI: 10.1152/ajpcell.00347.2024 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.12.2024. Verfasst von Christopher Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kinesiology, University of Massachusetts, Amherst, Massachusetts, United States. Hauptthemen laut MEDLINE: Aging, Muscle Fibers, Skeletal, Myosin Heavy Chains, Protein Isoforms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, HHS | NIH | National Institute on Aging (NIA).
Abstract (Originalsprache)
Human studies examining the cellular mechanisms behind sarcopenia, or age-related loss of skeletal muscle mass and function, have produced inconsistent results. A systematic review and meta-analysis were performed to determine the aging effects on protein expression, size, and distribution of fibers with various myosin heavy chain (MyHC) isoforms. Study eligibility included MyHC comparisons between young (18–49 yr) and older (≥60 yr) adults, with 27 studies identified. Relative protein expression was higher with age for the slow-contracting MyHC I fibers, with correspondingly lower fast-contracting MyHC II and IIA values. Fiber sizes were similar with age for MyHC I, but smaller for MyHC II and IIA. Fiber distributions were similar with age. When separated by sex, the few studies that examined females showed atrophy of MyHC II and IIA fibers with age, but no change in MyHC protein expression. Additional analyses by measurement technique, physical activity, and muscle biopsies provided important insights. In summary, age-related atrophy in fast-contracting fibers lead to more of the slow-contracting, lower force-producing isoform in older male muscles, which helps explain their age-related loss in whole muscle force, velocity, and power. Exercise or pharmacological interventions that shift MyHC expression toward faster isoforms and/or increase fast-contracting fiber size should decrease the prevalence of sarcopenia. Our findings also indicate that future studies need to include or focus solely on females, measure MyHC IIA and IIX isoforms separately, examine fiber type distribution, sample additional muscles to the vastus lateralis (VL), and incorporate an objective measurement of physical activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Kinesiology, University of Massachusetts, Amherst, Massachusetts, United States.
ORCID-Profile: Christopher Lee, Philip C Woods, Amanda E Paluch, Mark S Miller
Förderung
- NIA NIH HHS
- HHS | NIH | National Institute on Aging (NIA)
Zitieren
APA
Lee, C., Woods, P. C., Paluch, A. E., & Miller, M. S. (2024). Effects of age on human skeletal muscle: a systematic review and meta-analysis of myosin heavy chain isoform protein expression, fiber size, and distribution. American Journal of Physiology-Cell Physiology, 327(6), C1400-C1415. https://doi.org/10.1152/ajpcell.00347.2024
Vancouver
Lee C, Woods PC, Paluch AE, Miller MS. Effects of age on human skeletal muscle: a systematic review and meta-analysis of myosin heavy chain isoform protein expression, fiber size, and distribution. American Journal of Physiology-Cell Physiology. 2024;327(6):C1400-C1415. doi:10.1152/ajpcell.00347.2024
BibTeX
@article{Lee2024,
author = {Lee, Christopher and Woods, Philip C and Paluch, Amanda E and Miller, Mark S},
title = {Effects of age on human skeletal muscle: a systematic review and meta-analysis of myosin heavy chain isoform protein expression, fiber size, and distribution},
journal = {American Journal of Physiology-Cell Physiology},
year = {2024},
volume = {327},
number = {6},
pages = {C1400--C1415},
doi = {10.1152/ajpcell.00347.2024}
}
EUVIMED